The incidence of ventilator associated pneumonia (VAP) in critically ill patients: comparison of enteral (EN) versus parenteral (PN) nutrition support

ISRCTN ISRCTN86283280
DOI https://doi.org/10.1186/ISRCTN86283280
Secondary identifying numbers N0016141094
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
11/07/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mark Palazzo
Scientific

Intensive Care Unit
Charing Cross Hospital
Fulham Palace Road
Hammersmith
London
W6 8RF
United Kingdom

Phone +44 (0)20 8846 7018
Email m.palazzo@imperial.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleThe incidence of ventilator associated pneumonia (VAP) in critically ill patients: comparison of enteral (EN) versus parenteral (PN) nutrition support
Study objectivesCan the incidence of ventilator associated pneumonia be reduced by parenteral nutrition during the acute phase of critical illness?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNutrition support
InterventionProspective randomised open clinical study taking place at a single centre (ICU_CXH). Patients will be randomised to enteral (EN) versus parenteral (PN) nutrition support.
Intervention typeOther
Primary outcome measure1. Incidence of ventilator associated pneumonia
2. The number of ventilator free days
3. ICU length of stay
4. ICU mortality
Secondary outcome measuresNot provided at time of registration
Overall study start date29/03/2004
Completion date29/03/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaPatients expected to require ventilation for 5 or more days
Key exclusion criteriaNot provided at time of registration
Date of first enrolment29/03/2004
Date of final enrolment29/03/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Charing Cross Hospital
London
W6 8RF
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Hammersmith Hospital NHS Trust (UK)

No information available

NHS R&D Support (UK) - Funding 2004/05

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

11/07/2016: No publications found, verifying study status with principal investigator.